Results for tag: "Esophageal Cancer Drug"

Esophageal cancer is a type of cancer that affects the esophagus, the tube that connects the throat to the stomach. Oncology drugs are used to treat this type of cancer, and the esophageal cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of the disease, and can include chemotherapy, targeted therapy, and immunotherapy. Esophageal cancer drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as radiation therapy. The market for esophageal cancer drugs is expected to grow due to the increasing prevalence of the disease, as well as advances in drug development and delivery. Some companies in the esophageal cancer drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more